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Intercellular communication is essential in bone remodelling to ensure that
new bone is formed with only temporary bone loss. Monocytes (MCs) and
osteoclasts actively take part in controlling bone remodelling by providing
signals that promote osteogenic differentiation of mesenchymal stem/stro-
mal cells (MSCs). Extracellular vesicles (EVs) have attracted attention as
regulators of bone remodelling. EVs facilitate intercellular communication
by transferring a complex cargo of biologically active molecules to target
cells. In the present study, we evaluated the potency of EVs from MCs and
osteoclasts to induce a lineage-specific response in MSCs. We analysed gene
expression and protein secretion by both adipose tissue-derived MSCs and
bone marrow-derived MSCs after stimulation with EVs from lipopolysac-
charide-activated primary human MCs and (mineral-resorbing) osteoclasts.
Isolated EVs were enriched in exosomes (EVs of endosomal origin) and
were free of cell debris. MC- and osteoclast-derived EVs were taken up by
adipose tissue-derived MSCs. EVs from activated MCs promoted the secre-
tion of cytokines by MSCs, which may represent an immunomodulatory
mechanism. MC-derived EVs also upregulated the expression of genes
encoding for matrix metalloproteinases. Therefore, we hypothesize that
MCs facilitate tissue remodelling through EV-mediated signalling. We did
not observe a significant effect of osteoclast-derived EVs on gene expression
or protein secretion in MSCs. EV-mediated signalling might represent an
additional mode of cell-cell signalling during the transition from injury and
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inflammation to bone regeneration and play an important role in the cou-
pling between bone resorption and bone formation.
Database
Gene expression data are available in the GEO database under the accession number
GSE102401.
Introduction
Cells release diverse types of membrane vesicles into the
extracellular environment. These so-called extracellular
vesicles (EVs) represent an important mode of intercel-
lular communication by transferring a complex cargo of
biologically active molecules to target cells [1,2]. Given
the importance of cellular interactions in bone remod-
elling [3], EVs have attracted attention as regulators of
this process [4]. EVs could find use in the treatment of
bone diseases that are related to aberrant bone remod-
elling, such as rheumatoid arthritis, osteoarthritis and
osteoporosis [5]. Moreover, EVs have potential in regen-
erative medicine as biomimetic tools to induce lineage-
specific differentiation of stem cells [6,7]. The cell type
from which the most potent regulatory EVs originate
and the mechanism by which the EVs mediate bone
remodelling remain to be investigated [5,8].
The immune system strongly influences tissue repair
and regeneration, and active control of the immune
system is an attractive therapeutic approach to induce
tissue regeneration [9], including bone regeneration
[10]. The mononuclear phagocytic system is part of the
immune system and consists of hematopoietic cells
derived from progenitor cells in the bone marrow
(BM) [11]. Monocytes (MCs) and osteoclasts (OCs)
are mononuclear phagocytic cell types that share pre-
cursors. Both MCs [12,13] and OCs [14–16] actively
take part in controlling bone remodelling by providing
signals that promote osteogenic differentiation of mes-
enchymal stem/stromal cells (MSCs).
In the context of tissue healing, there are few studies
looking into the potential of EVs from mononuclear
phagocytes. Nevertheless, EVs from these cells most
likely have a role in the crosstalk between immunity and
tissue healing [17] and may contribute to maintaining
bone homeostasis [4]. In the present study, we evaluated
the potency of EVs from primary human MCs and OCs
to induce a lineage-specific response in MSCs. We anal-
ysed gene expression and protein secretion by both adi-
pose tissue-derived MSCs (AT-MSCs) and BM-derived
MSCs (BM-MSCs) after stimulation with EVs from
activated primary human MCs and OCs. The study
sheds light on the mechanism by which EVs mediate
bone remodelling and their potential as therapeutic
tools to enhance the regeneration of bone tissue.
Results
Culture of lipopolysaccharide-activated
monocytes and formation of osteoclasts on
tissue culture plastic and hydroxyapatite
coatings
Monocyte and OC cultures were monitored using a
phase-contrast microscope (Fig. 1). Lipopolysaccharide
(LPS)-activated MCs were visible as small adherent
cells. The conditioned medium from these cells was
collected at 3 days (Fig. 1A,B) and 5 days (Fig. 1C) of
culture. Part of the LPS-activated MCs was positive
for OC-marker tartrate resistant acid phosphatase
(TRAcP; Fig. 1B).
One of the aims of this study was to investigate the
effect of OC-EVs on the differentiation of MSCs.
Therefore, peripheral blood MCs were differentiated
towards OCs using macrophage colony-stimulating
factor (M-CSF) and receptor activator of nuclear fac-
tor j-B ligand (RANKL). MCs eventually fused and
formed OCs in presence of M-CSF and RANKL
(Fig. 1D,E). Nonactive OCs were generated on tissue
culture plastic (tissue culture polystyrene, TCPS). Hen-
riksen et al. [16] showed that pro-osteogenic signalling
of OCs is partially dependent on mineral dissolution.
To investigate if the potential EV-signalling from OCs
to MSCs is dependent on mineral dissolution, cells
were also cultured on a hydroxyapatite (HA) substrate
(Fig. 1H–K). HA coatings have been previously used
to model mineral dissolution by OCs [18,19]. The for-
mation of mature OCs was confirmed by the positive
staining for TRAcP (Fig. 1F). Mature OCs on HA
were dissolving the substrate (Fig. 1K,J).
Characterization of EVs from LPS-activated
monocytes and osteoclasts
Extracellular vesicles were obtained using an isolation
kit or by ultracentrifugation (UC) of the MC- and
OC-conditioned medium. The obtained particles were
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characterized for size, morphology and the presence or
absence of membrane proteins. Transmission electron
microscopy revealed the isolation of vesicles with an
intact lipid bilayer (Fig. 2A–F).
Nanoparticle tracking analysis showed that the large
majority (> 80%) of the particles isolated in this study
was between 50 and 200 nm in diameter (Fig. 3). The
number of particles between 50 and 400 nm in diame-
ter were considered EVs for the functional assays in
this study. Isolation using the kit resulted in a higher
number of EVs than isolation by UC (Table 1), espe-
cially from OCs cultured on TCPS. The number of
EVs recovered from MC-conditioned medium by UC
did not reach beyond the background levels of uncon-
ditioned LPS-supplemented medium. UC yielded big-
ger EVs, especially for MCs.
Western blotting revealed the presence of EV-
associated proteins CD90 (Thy-1), tumour susceptibility
gene 101 (TSG101) and 70 kilodalton heat shock pro-
teins (Hsp70; Fig. 4). TSG101 and Hsp70 were also
detected from MC lysate. CD63 (lysosomal-associated
membrane protein 3), a marker for EVs of endosomal
origin was only barely detectable extracellular vesicles
from lipopolysaccharide-activated MCs (MC-EVs).
CD63 was on the other hand highly enriched in EVs
from OCs cultured on both TCPS (OC TCPS-EVs) and
HA coatings (OC HA-EVs). MC and macrophage mar-
ker CD14 was present in all EV types, just like RANKL
receptor RANK. The CD14 and RANK signals were
minute in MC lysate. Calnexin, a protein of the endo-
plasmic reticulum, was only present in MC lysate.
Uptake of EVs by adipose tissue-derived-
mesenchymal stem/stromal cells
To show that the MC-EVs and OC-EVs could interact
with MSCs, we studied the uptake of the EVs by AT-
MSCs (Fig. 5). EVs were labelled with lipophilic dye
DiD before adding them to AT-MSC cultures. After
3 days of culture, labelled EVs from all three cell
sources were visible inside the AT-MSCs (Fig. 5B–D).
To exclude that DiD micelles or other background
staining would be mistaken for EVs, EV-free PBS was
stained with DiD and processed the same way. No
background staining was visible under the confocal
microscope when the cells had been incubated with the
control (Fig. 5A).
The interaction between AT-MSCs and MC-EVs
and OC-EVs was confirmed by flow cytometry analysis
(Fig. 5E–G). EV-positive AT-MSC fractions could be
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Fig. 1. Phase-contrast microscopy (A,C–E,G–I,K) and stainings for osteoclast-marker TRAcP (B,F,J) of LPS-activated MCs (A–C), osteoclasts
on TCPS (D–G) and osteoclasts on HA coatings (H–K). MC-conditioned medium was collected at 3 days (A,B) and 5 days (C) of culture.
Incomplete osteoclast formation (D) and intact HA coating (H) was observed at 5 days of osteoclast differentiation. Medium was changed
to medium depleted of EVs when osteoclasts had formed (E,I). Osteoclast-conditioned medium was collected 3 days (F,J) and 5 days (G,K)
after changing to EV-depleted medium. Scale bar: 100 lm.
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detected, defined as the fraction of the cells with a flu-
oresence higher than greater than that of 95% of AT-
MSCs incubated with the DiD-labelled control.
Microarray analysis of gene expression by AT-
MSCs cultured in the presence of monocyte- and
osteoclast-derived EVs
The effect of the MC-EVs and OC-EVs on gene
expression patterns in AT-MSCs was analysed using
microarrays. AT-MSCs were exposed to equal
numbers of MC-EVs or OC-EVs for a period of 18
days. The EVs had been isolated from the conditioned
media using the isolation kit. AT-MSCs cultured in
EV-depleted maintenance medium (MM) was the ref-
erence condition. Because gene expression patterns
related to osteoblast differentiation and bone remod-
elling were of interest in this study, we also included
AT-MSCs cultured in established osteogenic culture
conditions (osteogenic differentiation medium, ODM).
A total of 3187 genes were found to be differentially
expressed between the culture conditions (false discov-
ery rate < 0.05; Figs 6 and 7). We performed direct
quantification of nine selected gene transcripts by
quantitative PCR (qPCR) to validate the microarray
findings (Fig. 8). The qPCR analysis was performed
separately for each of the six donor replicates. In every
case, a strong correspondence between the microarray
and qPCR data was observed.
Figure 6 shows a heatmap of the genes that were
differentially expressed between the culture conditions.
Gene expression patterns of samples cultured in
ODM were most distinct from those in other condi-
tions. However, ODM did not result in a gene
expression pattern typical of (differentiating) osteo-
blasts. Osteogenic marker genes like RUNX2 or
ALPL stayed at similar or even slightly lower levels,
although not significant. Expression of BMP2, which
plays an important role in bone development, was
even substantially downregulated in ODM. When the
microarray results were validated by qPCR, BMP2
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Fig. 2. Transmission electron microscopy images of MC-EVs (A,D), OC TCPS-EVs (B,E) and OC HA-EVs (C,F). Close-ups (D,E,F) of the
regions marked in A, B and C, respectively. Scale bars: 100 nm.
Table 1. EV yield and median particle size based on nanoparticle
tracking analysis.




Donor 1 107 nm (86–158) 1.43 9 109
Donor 2 91 nm (77–124) 1.68 9 109
Donor 3 133 nm (107–198) 3.56 9 108
Donor 4 147 nm (112–193) 3.17 9 108
Osteoclasts on TCPS
Donor 1 114 nm (92–149) 1.17 9 1010
Donor 2 126 nm (98–163) 1.96 9 1010
Donor 3 134 nm (112–165) 7.42 9 108
Donor 4 131 nm (108–163) 5.40 9 108
Osteoclasts on HA
Donor 1 126 nm (96–155) 2.35 9 109
Donor 2 121 nm (93–157) 6.03 9 109
Donor 3 120 nm (97–155) 1.24 9 108
Donor 4 135 nm (112–170) 7.87 9 108
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expression levels were significantly lower in ODM
compared to MM (Fig. 8).
The gene expression patterns of cells from donor
pool was similar when these cells had been exposed to
OC TCPS-EVs, OC HA-EVs or when cultured in MM
without EVs (Fig. 6). The gene expression patterns
were more similar between these conditions than with
other donor pools in the same culture condition. This
reflects the similarity between these conditions and the
limited effect of OC-EVs on gene expression patterns
in AT-MSCs. Exposure to either OC TCPS-EVs or
OC HA-EVs, did not lead to significant regulation of
genes relative to EV-depleted MM (Fig. 7).
Stimulation with MC-EVs on the other hand resulted
in 176 upregulated genes and 251 downregulated genes
compared to EV-depleted MM (Fig. 7). Samples
exposed to MC-EVs show great similarity among the
different donor pools (Fig. 6). Genes that were differen-
tially expressed in the presence of MC-EVs showed great
overlap with genes differentially expressed in established
osteogenic induction conditions. Of the 427 genes that
were significantly regulated by MC-EVs, 211 were also
differentially expressed in ODM. The direction of regu-
lation, however, did not necessarily match. Of the 176
genes upregulated by MC-EVs, only 10 were also














































Fig. 3. Distribution of particles in MC-EVs, OC TCPS-EVs and OC HA-EVs according to nanoparticle tracking analysis. Particles were isolated
using the EV isolation kit for blood donors 1 and 2 and by UC for blood donors 3 and 4. UC precipitate from LPS-activation medium and
LPS-supplemented OCDM that had not been in touch with cells (unconditioned medium) were included as negative controls for MC-EVs
and OC-EVs, respectively. Particle concentration in each bin (10 nm in size) is expressed as the number of particlesmL1 of (un)conditioned
medium from which the particles originate.
Fig. 4. Western blots for EV-associated proteins CD90, TSG101,
CD63 and Hsp70, MC and macrophage marker CD14, RANKL
receptor RANK and endoplasmic reticulum protein calnexin in EVs
and MC lysate.
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upregulated in ODM and 53 genes were downregulated
in ODM. Of the 251 genes downregulated by MC-EVs,
107 were also downregulated in ODM and 41 were
upregulated.
Genes that were significantly upregulated by MC-
EVs include many genes encoding for cytokines
(Fig. 9). More specifically, CXC chemokines, such as
CXCL5 and CXCL3, and interleukin 1 (IL-1) cytoki-
nes, such as IL1RN and IL1B were expressed at higher
levels. In addition, exposure to MC-EVs led to expres-
sion levels of matrix metalloproteinases, such as
MMP3 and MMP1.
To characterize the function of the genes upregulated
by MC-EVs, an enrichment analysis of the genes was
performed by their functional annotation with gene
ontology (Fig. 10). Gene ontology terms for biological
processes reflecting the function of cytokines, such as
regulation of cell motility, positive regulation of cell
migration and positive regulation of immune system
processes were enriched for genes upregulated by MC-
EVs. Gene ontology terms for molecular functions
exerted by cytokines and chemokines in particular were
enriched, as well as the binding of receptors for CXCR
chemokines and IL–1 molecules. Enrichment of the
gene ontology term for metalloendopeptidase activity
reflects the increased expression levels of matrix metal-
loproteinases.
Biochemical analysis of AT-MSCs cultured in the
presence of monocyte- and osteoclast-derived
EVs
Quantification of alkaline phosphatase activity was
employed to evaluate the effect of MC-EVs or OC-EVs
on the early osteogenic differentiation of AT-MSCs
(Fig. 11). The observed effect of established osteogenic
conditions was only small. Exposure to MC-EVs led to
a slightly bigger increase in alkaline phosphatase activ-
ity. We did not observe an effect of OC TCPS-EVs or
OC HA-EVs on alkaline phosphatase activity.
Total collagen production was evaluated by quantifi-
cation of hydroxyproline content in the cell lysate.
ODM induced a small median increase in collagen
production compared to EV-depleted MM. Collagen
content had increased substantially under OC HA-EVs
stimulation for some samples. The effect from MC-
EVs was more consistent among the different donor
replicates causing a median 2-fold increase in collagen
content. We observed a slight decrease in collagen con-
tent when OC TCPS-EVs were used to stimulate AT-
MSCs.
According to Kruskal–Wallis one-way analysis of
variance by ranks, alkaline phosphatase activity and
collagen content were not equal in all conditions




























Fig. 5. EVs were added to cultures of AT-MSCs and uptake was examined after 72 h using confocal microscopy (A–D) and flow cytometry
(E–G). AT-MSCs were cultured with EV-free PBS control (A), with MC-EVs (B,E), OC TCPS-EVs (C,F) and OC HA-EVs (D,G), all stained
with lipophilic dye DiD. Blue: Hoechst 33342-stained nuclei, green: CellTraceTM CFSE-stained cell membrane, red: DiD-labelled EVs. Scale bar:
25 lm. Percentages denote DiD-positive fraction (grey area) in flow cytometry analysis with 5% overlap with cells cultured in PBS control.
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Gene expression and protein secretion by AT-
MSCs and BM-MSCs cultured in the presence of
monocyte- and osteoclast-derived EVs
Next, we assessed the difference between MSCs iso-
lated from adipose tissues and BM with respect to
their response to MC- and OC-EVs. LPS was added
to both MCs and OCs before the conditioned medium
was collected. EVs were isolated by UC. To control
for the effect of particles coprecipitated with the EVs,
we supplemented the MSC culture medium with UC
precipitate from LPS-activation medium (UC LPS)
and LPS-supplemented osteoclast differentiation med-
ium (UC OCDM) that had not been in touch with
cells. After culturing the AT-MSCs and BM-MSCs in
the presence of the EVs and controls without EVs, we
analysed gene expression using qPCR (Fig. 12). Genes
were chosen because of their relevance in osteoblast
differentiation or because they had been found
differentially expressed in MC-EV-stimulated AT-
MSCs in our microarrays. In addition, we assessed the
secretion of cytokines and soluble intercellular adhe-
sion molecule 1 (ICAM-1) at protein level (Fig. 13).
These experiments confirmed in large the results
obtained from the microarrays. Expression of CXCL5
was increased in the presence of MC-EVs for both
AT-MSCs and BM-MSCs (Fig. 12A). The difference
with UC LPS was statistically significant for BM-
MSCs. MMP1 expression levels were also slightly
increased in AT-MSCs in response to MC-EVs
(Fig. 12B). We did not detect differences in MMP1
expression levels in BM-MSCs in response to EVs.
MMP1 expression by BM-MSCs was substantially
decreased when BM-MSCs were cultured in ODM.
Culture in ODM slightly decreased expression levels of
ICAM1 in AT-MSCs (Fig. 12C), confirming our previ-
ous observation (Fig. 8F). In BM-MSCs on the other









































































Fig. 6. Heat map generated from
microarray data reflecting the Z-score of
gene expression values of AT-MSCs
cultured in EV-depleted MM, ODM or MM
supplemented MC-EVs, OC TCPS-EVs or
OC HA-EVs. Red denotes high gene
expression and blue denotes low gene
expression. The microarray was performed
using three distinct pools per condition (a,b
and C), assembled from five donor cell
replicates. The dendogram illustrates the
arrangement of clusters produced by
hierarchical clustering.
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levels in ODM than in MM. ICAM1 expression was
higher in the presence of EVs than in MM for both
MSC types, but a similar effect was seen in AT-MSCs
when cultured with UC precipitate without EVs. Stim-
ulation of BM-MSCs with MC-EVs and OC TCPS-
EVs caused a substantial increase in expression of
ICAM1 compared to the controls without EVs.
Expression of osteogenic marker genes ALPL and
RUNX2 were not affected by our experimental
conditions (Fig. 12D,E). BM-MSCs expressed RUNX2
at higher levels than AT-MSCs.
Monocyte-EVs stimulated the secretion of cytokines
by AT-MSCs, confirming our microarray results
(Fig. 13A–C). MC-EVs also increased cytokine secre-
tion by BM-MSCs, although the effect was less appar-
ent than for AT-MSCs. Due to the high variability
between the three donor repeats, no statistically signifi-
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Fig. 7. Vulcano plots of gene expression by AT-MSCs cultured in ODM (A) or exposed to MC-EVs (B), OC TCPS-EVs (C) or OC HA-EVs (D),
according to microarray analysis. Statistical significance (as false discovery rate in reversed log2 scale) is plotted against the fold change
(log2 scale) with AT-MSCs cultured in EV-free MM. Genes indicated as black dots are significantly differentially expressed based on
moderated paired t-tests and by controlling the false discovery rate (< 0.05). Five most up- and -downregulated genes are indicated.
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Fig. 8. Quantitative PCR analysis of gene expression of ACAN (A), ALPL (B), BMP2 (C), COL15A1 (D), FGL2 (E), ICAM1 (F), ITGA3 (G),
MMP1 (H) and RUNX2 (I) in AT-MSCs cultured in EV-free MM, EV-free ODM or AT-MSCs exposed MC-EVs, OC TCPS-EVs or OC HA-EVs.
Gene expression levels (log2 scale) are shown relative to the median gene expression in MM. *False discovery rate-controlled P-value
< 0.05, based on Mann–Whitey U-tests with MM. [Colour figure can be viewed at wileyonlinelibrary.com]
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secretion by MSC-EV-stimulated AT-MSCs and the
control (UC LPS). The conditioned medium from
MSCs cultured with OC TCPS-EVs also contained
slightly elevated levels of cytokines. The chemokines
CCL2 (chemokine [C–C motif] ligand 2) and IL8 were
already present in the OC TCPS-EV-supplemented
medium. Chemokines CCL5, chemokine [C–X–C
motif] ligand 9 (CXCL9) and CXCL10 were not
detected by the human chemokine kit.
Mesenchymal stem/stromal cells secreted soluble
ICAM-1 in response to MC-EVs and OC-EVs
(Fig. 13D). ICAM-1 secretion in response to the EVs
showed similarities with cytokine secretion. AT-MSCs
secreted the most ICAM-1 in response to MC-EVs,
just like we observed for cytokines. Highest ICAM-1
concentrations in BM-MSC-conditioned medium were
measured from cultures with OC-TCPS-EVs, but like
cytokines, soluble ICAM-1 was already present in the
OC TCPS-EV-supplemented medium before MSCs
were cultured.
Discussion
Tight control of bone remodelling through cellular
interactions is essential to ensure that new bone is
formed with only temporary bone loss. Many cell types
and molecular mechanisms contribute to coupling
between bone resorption and bone formation [3]. EVs
from mononuclear phagocytes most likely have a role in
maintaining bone homeostasis [17]. EVs from LPS-
activated MCs for instance, were found to increase
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Differentially expressed genes in AT−MSCs exposed to MC−EVs
Fig. 9. Differentially expressed genes in AT-MSCs exposed to MC-EVs according to microarray analysis. Bars indicate gene expression
levels (log2 scale) relative to AT-MSCs in EV-free MM. Darker shade of the bar denotes higher statistical significance of the difference with
MM based on a moderated paired t-test and false discovery rate controlling procedures.
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BMP2 and BGLAP and were suggested to constitute an
additional mode of cell-cell signalling during the transi-
tion from injury and inflammation to bone regeneration
[20]. OCs couple their bone-resorbing activity to the
activity of osteoblasts by providing signals that promote
osteogenic differentiation of MSCs and coordinate
osteoblastic bone formation [14–16]. We wanted to find
out if the osteoinductive signals from OCs to MSCs are
partially carried by EVs.
We compared the effects of EVs from LPS-activated
MCs and OCs at a genome-wide scale. Unlabelled
MCs were obtained by depletion of non-MCs using a
cocktail of antibody-conjugated microbeads. Positive
selection of CD14+ MCs using anti-CD14 microbeads
would block CD14, which functions as a receptor for
LPS [21]. This would lead to an inability of the MCs
to be activated by LPS stimulation, which is thought
to lead to more profound and prolonged osteoinduc-
tive signalling to MSCs [22]. When experiments were
repeated, we also added LPS to the OC cultures to
make comparison between the effects of MC-EVs and
OC-EVs more straightforward. We hypothesized that
EVs represent a part of the osteoinductive signals from
OCs to MSCs that depends on the resorption activity
Localization of cell
Regulation of cell motility
Positive regulation of cellular component movement
Positive regulation of locomotion
Cell chemotaxis
Positive regulation of cell migration
Positive regulation of immune system process
Cell surface receptor signaling pathway
Response to organic substance
Taxis




CXCR chemokine receptor binding
Cytokine receptor binding
Cytokine activity
G−protein coupled receptor binding








Fig. 10. Gene ontology terms for biological
processes and molecular functions that are
most enriched for genes significantly
upregulated by MC-EVs. Enrichment















































































Fig. 11. Relative alkaline phosphatase activity and total collagen content in AT-MSCs cultured in EV-depleted MM, EV-depleted ODM or
MM supplemented with MC-EVs, OC TCPS-EVs or OC HA-EVs. Results are normalized for cell number and expressed relative to the
median in MM.
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by OCs [16]. Mineral resorbing OCs were therefore
included as an EV source. OCs were activated for min-
eral resorption by culturing them on coatings of HA.
EV isolation method affected EV yield, but did
not change the response in MSCs
We used a kit to isolate the EVs from the cell-
conditioned medium for the microarray experiments.
The isolation kit works by lowering the hydration of the
EVs, thereby reducing their solubility and allowing pre-
cipitation of the EVs at lower centrifugal forces. The
main advantage of this type of kits is the ability to iso-
late EVs from a large volume of conditioned medium in
a relatively short period of time. However, these kits
usually give lower purity than e.g. UC, as the solubility
of almost all particles decreases equally [23]. When we
repeated the experiments and included BM-MSCs
exposed to the EVs, we had isolated the EVs by UC.
The particle yield in the UC precipitate was much lower
than in the kit’s isolate (Fig. 3 and Table 1). It is possi-
ble that most particles isolated using the kit were not
EVs. Nevertheless, experiments using kit isolates and
using EVs obtained by UC lead to similar results. We
included EV-free controls for UC and obtained rela-
tively high background levels. The effects of coprecipi-
tated particles on gene expression and cytokine
secretion by MSCs, though, were still minor compared
to the effects of the EVs, especially MC-EVs.
More EVs were obtained from OCs on TCPS, with
the exception of blood donor 4. The higher yield from
OCs on TCPS than on the HA coatings could be
explained by better attachment of the cells on TCPS,
resulting in higher cell proliferation than on HA. Con-
sequently, more cells were available to produce EVs.
EV isolates were enriched in exosomes and were
free of cell debris
Detection and characterization of EVs in a standard-
ized manner have proven difficult [24]. EV are there-
fore often characterized using a combination of
methods. We identified EVs based on their size, pres-
ence of proteins and their biological activity according
to the minimal criteria parameters recommended by
the International Society of EVs [25]. Overall,
morphology and size distribution of the particles indi-
cated an enrichment in exosomes, EVs of endosomal
origin between 40 and 100 nm in diameter [26].
The presence of CD90 argues for the presence of
membrane in the isolate and is a general EV marker [25]
(Fig. 4). EVs can bear Hsp70 when they are exposed to
stress conditions [27], and could be upregulated upon
LPS stimulation [28]. The presence of TSG101 is more
specific for exosomes: TSG101 is required for the sort-
ing of cargo into exosomes [29]. Interestingly, there was
a strong signal from tetraspanin CD63 in OC-EVs,
while it was almost absent in MC-EVs. Tetraspanins are
widely used as exosome markers, because of their role in
biogenesis, assembly, and sorting of protein and genetic
material into exosomes [27]. Our other results do, how-
ever, not suggest a shift in EV population from
microvesicles to exosomes when MCs differentiate
towards OCs. This shows the difficulty in finding com-
mon EV/exosome marker proteins for EVs derived from
different cell types, even if those cells stem from the
same population.
Monocyte-EVs and OC-EVs were both positive for
CD14, reflecting the cell membrane of the MC and
shows that CD14 is still expressed on the EV surface
once MCs have differentiated into OCs. In accordance
with Huynh et al. [30], we detected RANK in the EVs
from mature OCs. The RANK-rich EVs may function
by competing with RANK+ OC precursors for
RANKL, thereby inhibiting their own formation [30].
The MC-EVs also expressed RANK, contrary with the
previously reported RANK-negative EVs from primary
mouse marrow-derived OC precursors [30]. This shows
that precursor cells derived from different tissues and
animals might differ in the EVs they produce and the
way these EVs function in regulating differentiation.
As mentioned above, impurities in the samples
might affect the results. We can rule out major con-
taminations consisting of cell debris, because endoplas-
mic reticulum protein calnexin was absent.
Isolated monocyte- and osteoclast-derived EVs
were functional and adipose tissue-derived MSCs
are one of their targets
Apart from sample purity, it is important that the iso-
lated EVs are functional. Our results show that the
Fig. 12. Quantitative PCR analysis of gene expression of CXCL5 (A), MMP1 (B), ICAM1 (C), ALPL (D) and RUNX2 (E) in AT-MSCs (pink fill)
and BM-MSCs (blue fill). MSCs were cultured in EV-free MM, ODM or exposed to MC-EVs, OC TCPS-EVs or OC HA-EVs. In addition,
MSCs were cultured in MM supplemented with UC LPS or UC OCDM. Gene expression levels (log2 scale) are shown relative to the
median gene expression in MM. Pink and blue bars indicate median expression for AT-MSCs and BM-MSCs, respectively. *False discovery
rate-controlled P-value < 0.05, based on paired t-tests for CXCL5 expression in BM-MSCs between MC-EVs and UC LPS (A) and for ICAM1
expression in BM-MSCs between ODM and MM (C).
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isolated EVs were able to interact with target cells: AT-
MSCs took up both MC-EVs and OC-EVs (Fig. 5).
The same was previously found for BM-MSCs that
took up EVs from LPS-activated MCs [20]) and den-
dritic cells [31], another mononuclear phagocytic cell
type. These results suggest that many, if not all,
mononuclear phagocytes interact with MSCs through
their EVs. The EVs were found in clusters close to the
nuclei, suggesting active endocytosis of the EVs leading
to processing of their molecular cargo [31]. Other
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Fig. 13. Protein concentrations of CCL2 (A), IL-8 (B), IL-6 (C) and soluble ICAM-1 (D) measured using cytometric bead arrays in the AT-MSCs
(pink fill) and BM-MSCs (blue fill). MSCs were cultured in EV-free MM, ODM or exposed to MC-EVs, OC TCPS-EVs or OC HA-EVs. MSCs
were also cultured in MM supplemented with UC LPS or UC OCDM. Pink and blue bars indicate median expression for AT-MSCs and BM-
MSCs, respectively. The protein concentration in the (supplemented) culture media before MSC culture are marked with the letter M.
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mechanisms of interaction with the AT-MSCs cannot
be ruled out, such as EV-mediated activation of mem-
brane-bound receptors that trigger signalling pathways,
or fusion with the cell membrane leading to release of
the EV cargo into the cell cytoplasm [24].
Ekstr€om et al. [20] found that uptake of MC-EVs
by BM-MSCs differed largely between cells within the
same culture and also between different experiments.
Uptake of EVs could be affected by proliferation sta-
tus and membrane composition [20]. Differences in
uptake efficiency between the EVs of different origin
were not the main interest of this study and would
require a different experimental set-up. Conclusions
EV-MSC interaction based on different numbers of
DiD-labelled EVs inside the AT-MSCs (Fig. 5A–D) or
on EV-positive AT-MSC fractions (Fig. 5E–G) should
therefore be taken with care.
Isolated monocyte- and osteoclast-derived EVs
carry different signals to MSCs
Current scientific literature is not unanimous about the
effects of EVs derived from mononuclear phagocytes
on MSCs. EV derived from LPS-activated MCs were
reported to stimulate osteogenic differentiation of
MSCs [20] and similar results have been reported for
dendritic-cell derived EVs [32]. Silva et al. [31] on the
other hand did not find any effects of dendritic-cell
derived EVs on osteogenic differentiation, despite the
accumulation of these EV inside the MSCs. Also the
interactions between OCs, osteoblasts and mesenchy-
mal precursors partially take place through tranfer of
EVs. These interactions can also inhibit osteoblast
activity, as OC-EVs are able to transfer miR-214-3p to
inhibit osteoblast activity in vitro and reduce bone for-
mation in vivo [33,34].
In the present study, we did not observe a significant
effect of OC-EVs on gene expression in MSCs (Fig. 7).
We chose to culture the AT-MSCs in equal numbers
of MC- and OC-EVs in the microarray experiments, in
order to compare their potency to change AT-MSC
gene expression. When we analysed gene expression
and protein secretion by AT-MSCs and BM-MSCs,
we used EVs isolated from the same volume of condi-
tioned medium so that they came from cultures with
the same number of initially seeded MCs. OC-EVs did
not have or had a smaller effect than MC-EVs, at least
for the genes and proteins that we analysed (Figs 12
and 13). We cannot exclude that OC-EVs trigger sig-
nalling pathways different from the ones activated by
MC-EVs, but that we would only detect if we had
used more EVs. Characterizing the molecular cargo
carried by MC-EVs and OC-EVs would provide
insight in how the regulating potential of EVs changes
when MCs differentiate into OCs.
Monocyte-derived EVs promote the secretion of
various cytokines in MSCs, representing an
immunomodulatory mechanism
Mesenchymal stem/stromal cells interact with the
immune system by secreting anti-inflammatory factors,
as well as by expressing cell surface molecules that
suppress the maturation, activation and function of
immune cells [35]. Their immunosuppressive properties
make MSCs a relevant cell source when considering
immunomodulation therapies and allogeneic stem cell
treatments [36]. The immunosuppressive effects of
MSCs are at least partially mediated by EVs [37].
Here, we show that MC-EVs upregulated the secretion
of various cytokines by MSCs. Chemokine secretion
by MSCs may represent an immunomodulatory mech-
anism in which chemotaxis brings specific immune cell
subsets in close proximity to MSCs, which makes them
more susceptible for the immunosuppressive actions of
MSCs [38,39]. The response to MC-EVs was stronger
in AT-MSCs than in BM-MSCs, reflecting the greater
immunomodulatory potency of AT-MSCs [36].
Exposing MSCs to the UC precipitate of uncondi-
tioned LPS-supplemented medium (UC LPS and UC
OCDM) did not affect gene expression nor protein
secretion, except for ICAM1 expression and the secre-
tion of its protein product in AT-MSCs. We suspect
that traces of LPS in the UC precipitate upregulated
the expression of ICAM1. Upregulation of ICAM1 in
response to LPS has been long known in epithelial
cells [40–42], but has so far not been reported in
MSCs. LPS can suppress the osteogenic differentiation
potential of MSCs through the Toll-like receptor 4
mediated nuclear factor jB pathway [43]. The differen-
tiation potential of BM-MSCs, however, is not
affected by LPS, showing that the response to LPS is
dependent on the tissue source of the MSCs [43]. Like-
wise, in the present study, ICAM1 expression in BM-
MSCs was not affected by UC LPS and UC OCDM.
Addition of EVs did not lead to differential expression
of ICAM1 compared to the aforementioned controls.
Monocyte-derived EVs upregulated expression of
MMPs and might drive tissue remodelling
processes
After OCs have finished resorbing a packet of bone,
collagen fibrils are left in the resorption pit that pro-
trude from the bone surface. The collagen fibrils need
to be removed before new bone formation can take
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place [44]. It has long been unknown which cells are
responsible for the removal of these collagen fibrils.
Given that mononuclear cells (lymphocytes and MCs)
reside near the bone surface, it has been suggested that
mononuclear phagocytes are involved in their removal
[45]. Our data confirm that MCs might play a role by
stimulating collagen removal through EV-mediated sig-
nalling. MC-EVs upregulated the expression of
MMPs, thereby stimulating processes related to the
reorganization of the extracellular matrix structure, in
particular the removal of collagens. We show that
MMPs are overexpressed in MSCs, suggesting that
cells of mesencymal lineages start to remove collagens
in response to the presence and activation of MCs.
These results confirm the suggestion that bone lining
cells clean the bone surface before new bone formation
takes place [44]. Bone lining cells are mesenchymal
cells and although bone lining cells do not form bone,
they belong to the same lineage as osteoblasts.
Although speculative, signals from MCs, combining
both soluble factors and MC-EV interactions, may
direct MSCs to differentiate towards bone lining cells.
Our results show the importance of EV-mediated
signalling between MCs and MSCs for controlling the
function of the immune system. The promotion of
cytokine secretion by MC-EVs may enhance the
immunosuppressive actions of the MSCs. EV-mediated
signalling might represent an additional mode of inter-
cellular communication during the transition from
injury and inflammation to bone regeneration. The
upregulation of MMPs suggests an important role of
MC-EVs in the coupling between bone resorption and
bone formation. Characterizing the molecular cargo
carried by MC-EVs and OC-EVs would provide
insight in how the regulating potential changes of the
EVs when MCs differentiate into OCs.
Conclusion
Our results show the importance of EV-mediated sig-
nalling between MCs and MSCs for controlling the
function of the immune system. MC-EVs promoted the
secretion of various cytokines by MSCs. Chemokine
secretion by MSCs may represent an immunomodula-
tory mechanism in which chemotaxis brings specific
immune cell subsets in close proximity to MSCs, which
makes them more susceptible for the immunosuppres-
sive actions of MSCs. MC-EVs form promising pro-
spects for the development of MSC-based immune
therapy by enhancing the immunosuppressive actions of
the MSCs.
Monocyte-EVs upregulated the expression of MMPs,
thereby stimulating processes related to the reorgani-
zation of the extracellular matrix structure. Signals
secreted by MCs may direct MSCs to differentiate
towards bone lining cells. EV-mediated signalling might
represent an additional mode of cell-cell signalling dur-
ing the transition from injury and inflammation to bone
regeneration and play an important role in the coupling
between bone resorption and bone formation.
In the present study, we did not observe a significant
effect of OC-EVs on gene expression in MSCs. We
cannot exclude that OC-EVs trigger signalling path-
ways different from the ones activated by MC-EVs.
Characterizing the molecular cargo carried by MC-
EVs and OC-EVs would provide insight in how the
regulating potential changes of the EVs when MCs dif-
ferentiate into OCs.
Material and methods
Preparation of hydroxyapatite coatings in 24-well
culture plates
Hydroxyapatite coatings were deposited in 24-well culture
plates in a two-step procedure consisting of precalcification
and crystal growth as described by Patntirapong et al. [18].
The 24-wells were precalcified using a 3 9 concentrated
simulated body fluid (SBF 9 3) into each well. SBF 9 3
was prepared by mixing calcium solution (820 mM NaCl,
8.9 mM MgCl26H2O, 105 mM CaCl22H2O) and phosphate
solution (25 mM NaHCO3, 1.9 mM NaHPO42H2O), both
of which were prepared in 50 mM Tris HCl buffer solution
at pH 7.4. Freshly prepared SBF 9 3 solution was added
to each well (1.5 mL) and refreshed daily during a 3-day
incubation period at room temperature. This resulted in the
formation of a thin amorphous calcium phosphate coating
that acted as nucleation layer for crystal growth in the sec-
ond step. At the end of the precalcification, the wells were
thoroughly washed in distilled H2O and dried at 50 °C.
In the second step, calcium phosphate solution was pre-
pared by dissolving 140 mM NaCl, 4 mM CaCl22H2O and
2.6 mM NaHPO42H2O in 50 mM Tris HCl buffer at pH
7.4. Calcium phosphate solution was added to the precalci-
fied wells (1.5 mL) and refreshed daily during a 3-day incu-
bation period at room temperature. The resulting HA
coatings resemble the mineral component of bone. The HA
coated wells were thoroughly washed in distilled H2O and
dried at 50 °C. Before use for cell cultures, the wells were
sterilized by soaking in 70% ethanol and drying under
ultraviolet light for 20 min.
Isolation of human monocytes
Human buffy coats were obtained from the Finnish Red
Cross Blood Service (Helsinki, Finland). Buffy coats were
left from the processing of blood collected from healthy
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voluntary blood donors. Before blood donation, donors are
informed that blood samples that are not required for
patient treatment can be used anonymously for research
work. The use of buffy coats for this project was approved
by the ethical committee of the Finnish Red Cross Blood
Service. The study methodologies conformed to the stan-
dards set by the Declaration of Helsinki.
Monocytes were isolated from 40 mL of buffy coat in a
two-step procedure [46]. Briefly, peripheral blood mononu-
clear cells (PBMCs) were extracted from the buffy coats by
gradient centrifugation. The buffy coat was diluted 1 : 1 with
PBS and gently layered on top of LymphoprepTM (StemCell
Technologies, Vancouver, Canada). The gradient was cen-
trifuged for 30 min at 800 g with the brake off. The PBMC
layer was collected and washed several times with PBS.
Monocytes were isolated from the PBMC fraction by
depletion of non-MCs (negative selection) using a MC
Isolation kit II (Miltenyi Biotech, Bergisch Gladbach, Ger-
many) according to the manufacturer’s instructions. Briefly,
non-MCs were indirectly magnetically labelled with a
cocktail of biotin-conjugated monoclonal antibodies against
CD3, CD7, CD16, CD19, CD56, CD123 and Glycophorin
A. Anti-biotin monoclonal antibodies conjugated to
microbeads were used to magnetically label non-MCs
which were then retained in a magnetic field.
Culture of monocytes and generation of
osteoclasts
Monocytes were plated at a density of 1.5 9 105 cellscm2
in 24-well plates, either on TCPS or coatings of HA. MCs
were either activated by culturing in MM supplemented
with 10 ngmL1 LPS (LPS-activation medium, Table 2) or
stimulated to generate OCs in OCDM (Table 2). The cells
were cultured at 37 °C and 5% CO2 in a humidified atmo-
sphere. The culture medium was refreshed every 2–3 days.
LPS-activated MCs were cultured in EV-depleted medium
from the start of the culture. The OC differentiation cul-
tures were changed to EV-depleted OCDM once OCs had
formed. EV-depleted OCDM was supplemented with LPS
for the culture of cells from blood donors 3 and 4. EV-
depleted medium was prepared with FBS depleted of EVs
by UC for 19 h at 120 000 g (26 000 r.p.m. in an Optima
LE-80K ultracentrifuge equipped with an SW-28 swinging-
bucket rotor, Beckman Coulter, Inc., Brea, CA, USA).
At the beginning of the conditioned medium collection,
samples were taken by fixing of the cells in 4%
paraformaldehyde (Sigma-Aldrich, Saint Louis, MO, USA).
To confirm the formation of OCs, the cells were stained for
IC-specific marker TRAcP using the Leucocyte acid phos-
phatase kit (Sigma-Aldrich) according to the manufacturer’s
instructions. During the culture and after the staining, cells
were monitored and imaged using a Nikon Eclipse TS100
inverted phase-contrast microscope (Nikon Corporation,
Tokyo, Japan) equipped with a Nikon DS-Fi2 camera.
Collection of monocyte- and osteoclast-condition
medium and isolation of extracellular vesicles
The conditioned medium was collected from the LPS-acti-
vated MCs at 3 and 5 days of culture. The conditioned
medium from OCs was collected 3 days and 5 days after
changing to EV-depleted medium. The conditioned medium
was depleted of cell debris by centrifuging for 20 min at
2500 g and the supernatant was filtered through a 0.45 lm
sterile filter (Merck, Darmstadt, Germany).
For blood donors 1 and 2, EVs were isolated from
the conditioned medium using an isolation kit. The miR-
CURYTM Exosome Isolation Kit (Exiqon A/S, Vedbæk,
Denmark) was used according to the manufacturer’s
instructions. Briefly, hydration of particles was diminished
by mixing the media with the precipitation buffer provided
in the kit. After incubation at 4 °C for minimally 1 h, the
EVs were precipitated by centrifugation at 3000 g for
30 min. The supernatant was removed and the pellet was
resuspended in the resuspension buffer provided in the kit.
EVs were stored at 75 °C until further use.
For blood donor 3 and 4, EVs were isolated from the con-
ditioned medium by UC for 2 h at 120 000 g. The UC precip-
itate was washed by adding a large volume of filtered PBS
(0.1 lm filter), after which UC was repeated. EVs were resus-
pended in filtered PBS and stored at 75 °C until further use.
Characterization of monocyte- and osteoclast-
derived extracellular vesicles
Monocyte-EVs, OC TCPS-EVs or OC HA-EVs were char-
acterized using transmisssion electron microscopy, nanopar-
ticle tracking analysis and western blotting.
Table 2. The compositions of media used in the study
MM DMEM/F-12 with GlutaMAXTM
(Gibco, Thermo Fisher Scientific), 10%
FBS (Gibco), 100 unitsmL1 penicillin
and 100 lgmL1 streptomycin (Gibco)
EV-depleted MM DMEM/F-12 with GlutaMAXTM, 10%
EV-depleted FBS, 100 unitsmL1
penicillin and 100 lgmL1 streptomycin
LPS-activation medium EV-depleted MM, 10 ngmL1 LPS
(Escherichiea coli O111: B4, Merck
Millipore, Billerica, MA, USA)
(EV-depleted) OCDM (EV-depleted) MM, 10 ngmL1
recombinant human macrophage
colony-stimulating factor (M-CSF, R&D
systems), 20 ngmL1 RANK-L
(Peprotech, Rocky Hill, NJ, USA),
(10 ngmL1 LPS)
EV-depleted ODM EV-depleted MM, 50 lM L-Ascorbic acid
2-phosphate (Sigma-Aldrich), 10 mM
b-glycerophosphate disodium
salt hydrate (Sigma-Aldrich), 100 nM
dexamethasone (Sigma-Aldrich)
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Extracellular vesicles were washed by diluting in PBS
and ultracentrifuged for 2 h at 120 000 g. The EV samples
were resuspended in PBS and prepared for transmisssion
electron microscopy as described previously [47]. After
loading to 200 mesh copper grids and fixation with 2%
paraformaldehyde in 0.1 M NaPO4 buffer (pH 7.0), samples
were washed with the 0.1 M NaPO4 buffer and deionized
water, negatively stained with 2% neutral uranyl acetate
and embedded in methyl cellulose uranyl acetate mixture
(1.8/0.4%). Samples were viewed with transmisssion elec-
tron microscopy using Tecnai 12 (FEI Company, Eind-
hoven, the Netherlands) operating at 80 kV. Images were
taken with Gatan Orius SC 1000B CCD-camera (Gatan
Inc., Pleasanton, CA, USA) with 4008 9 2672 px image
size and no binning.
Nanoparticle tracking analysis was used to quantify and
determine the size distribution of particles in the EV sam-
ples. EV samples were diluted in PBS and injected into
the NanoSight LM14 (NanoSight Ltd., Salisbury, UK)
equipped with a blue laser (405 nm, 60 mW) and a sCMOS
camera. Three videos of 60 s (1498 frames each) were
recorded and analysed using NANOSIGHT software v3.0 (Par-
ticular Sciences Ltd, Dublin, Ireland). Particles between 50
and 400 nm in diameter were considered EVs.
Western blotting was performed as described previously
[47]. The following antibodies were used: mouse anti-Thy1
(CD90; Sigma-Aldrich, clone 3F9, 1 : 500), rabbit anti-
TSG101 (Sigma-Aldrich, polyclonal, SKU HPA006161, 1 :
500), mouse anti-Hsp70 (BD Biosciences, Becton Dickin-
son, Franklin Lakes, NJ, USA, clone 5G10, 1 : 1000),
mouse anti-CD63, (BD Biosciences, clone H5C6, 1 : 1000),
mouse anti-CD14 (R&D systems, Minneapolis, MN, USA,
clone 134603, 1 : 1000), mouse anti-RANK (receptor acti-
vator of nuclear factor the conditioned medium using an j-
B; Novus Biologicals, Littleton, CO, USA, clone 9A725, 1 :
1000) and rabbit anti-calnexin (Cell Signaling Technology,
Leiden, the Netherlands, clone C5C9, 1 : 800). EVs were
isolated by UC from equal volumes of conditioned medium
and loaded to the gel. Protein from MC lysate was loaded
to the gels as a control. EV samples were denatured at
95 °C for 5 min in reducing Laemmli sample buffer, sepa-
rated using Mini-PROTEAN TGXTM 4–20% gradient
SDS/PAGE gels (Bio-Rad, Hercules, CA, USA) with page
ruler prestained protein ladder (Thermo Fisher Scientific,
Waltham, MA, USA) as a standard and blotted on Immo-
bilon-P poly(vinylidene difluoride) membrane (Merck).
Blocking and antibody incubations were performed in
Odyssey blocking buffer (LI-COR BioSciences, Lincoln,
NE, USA) without and with 0.1% Tween-20, respectively.
Membranes were subsequently probed with IRDye
800CW Goat anti-Mouse (LI-COR) at 1 : 15 000 for 2 h
at room temperature. After incubation, membranes were
washed three times in TBS-T for 10 min at room tempera-
ture and imaged on an Odyssey FC Imager (LI-COR).
Anti-CD63 was applied to nonreduced samples.
We have submitted all relevant data of our EV experi-
ments to the EV-TRACK knowledgebase (EV-TRACK ID:
EV170018) [48].
Isolation and characterization of adipose tissue-
derived and bone marrow-derived mesenchymal
stem/stromal cells
The use of human MSCs confirmed to the standards set by
the Declaration of Helsinki.
Human AT-MSCs were obtained from water-assisted
lipotransfer liposuction aspirates [49] from nine female
donors (median age 44.5, range: 32–60) using mechanical
and enzymatic isolation as described previously [50]. The
study was carried out under approval of the ethical com-
mittee of Helsinki and Uusimaa Hospital District and with
informed consent from the donors.
Human BM-MSCs were isolated as described previously
with slight modifications [51]. BM was obtained under
approval of the ethical committee of the Pirkanmaa Hospi-
tal District (R15174) and the written consent of the
patients. The BM was diluted 1 : 3 with Dulbecco’s PBS
(Gibco; Thermo Fisher Scientific). The mixture was lay-
ered on a Histo Paque-1077 (Sigma-Aldrich) cushion and
centrifuged at 800 g for 20 min at room temperature.
Mononuclear cells were collected from the liquid interface
and washed with aMEM (Lonza, Basel, Switzerland).
The MSCs were expanded in MM (Table 2) at 37 °C
and 5% CO2 in a humidified atmosphere.
After expansion, MSCs were characterized using a BD
AccuriTM C6 flow cytometer (Becton Dickinson) to confirm
the mesenchymal origin of the cells. We used monoclonal
antibodies conjugated with allophycocyanin against CD14
(clone M5E2, 1 : 25), CD19 (clone HIB19, 1 : 25), CD34
(clone 581, 1 : 33), CD45RO (clone UCHL1, 1 : 33), CD54
(clone HA58, 1 : 33), CD73 (clone AD2, 1 : 143), CD90
(clone 5E10, 1 : 330), CD105 (clone 266, 1 : 100) and
HLA-DR (clone G46-6, 1 : 25), all purchased from BD
PharmingenTM (Becton Dickinson). Analysis was performed
on 1 9 105 events per sample and positive expression was
defined as the level of fluorescence > 99% of the corre-
sponding unstained cell sample.
Adipose tissue-MSCs and BM-MSCs demonstrated high
expression of CD73 (ecto-50-nucleotidase), CD90 (Thy-1)
and CD105 (endoglin) and no or low expression of CD14
(MC and macrophage marker), CD19 (dendritic cell mar-
ker), CD45 (pan-leucocyte marker) and HLA-DR (human
leucocyte antigen class II; Table 3). Moderate expression of
CD34 (haemopoetic progenitor cell antigen) and CD54
(ICAM-1) in AT-MSC conforms to previous reports for cul-
ture in FBS [52]. The results showed that MSCs expressed
most of the specific antigens that define human stem cells of
mesenchymal origin according to the criteria set by the Mes-
enchymal and Tissue Stem Cell Committee of the ISCT [53].
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Uptake of monocyte- and osteoclast-derived EVs
by adipose tissue-derived mesenchymal stem/
stromal cells
Extracellular vesicles were labelled in 1 lM DiD lipophilic
dye (Thermo Fisher Scientific) for 1 h at room tempera-
ture. The unbound dye was removed by adding a large vol-
ume of PBS and UC for 2 h at 120 000 g. The washing
step was performed twice before resuspending the EV pellet
in EV-depleted MM. DiD-labelled PBS without EVs was
processed the same way to serve as a control.
Adipose tissue-MSCs from donor 7 were seeded in 8-well
chamber slides (Ibidi GmbH, Planegg, Germany) at pas-
sages 4 or 7 and 1 9 104 cellscm2. The cells were allowed
to attach in MM overnight before the medium was changed
to EV-depleted MM supplemented with 3 9 109 DiD-
labelled EVsmL1 based on nanoparticle tracking analysis
(1.5 9 105 EVs per cell), or to EV-depleted MM supple-
mented with the PBS control. After 3 days, the cells were
labelled with 5 lM CellTraceTM CFSE dye (Thermo Fisher
Scientific) and 1 lgmL1 Hoechst 33342 (Sigma-Aldrich),
both for 20 min at 37 °C. The cells were washed prior to
imaging. Microscopy was performed on a TCS CARS SP8
confocal microscope (Leica Microsystems GmbH, Wetzlar,
Germany) with a 639 water immersion objective.
After imaging, cells were detached by trypsin treatment
and analysed by flow cytometry (BD Accuri C6). DiD
fluorescence intensity was detected using the FL4 channel
(675/25 nm laser). The data were analysed and visualized
using R Statistical Software (R Foundation for Statistical
Computing, Vienna, Austria).
Exposure of adipose tissue-derived and bone
marrow-derived mesenchymal stem/stromal cells
to monocyte- and osteoclast-derived EVs
Adipose tissue-MSCs and BM-MSCs were seeded in 96-well
plates at passages 4–6 and 2.5 9 103 cellscm2. The cells
were allowed to attach in MM overnight before the medium
was changed to EV-depleted MM supplemented with
3 9 109 EVsmL1 based on nanoparticle tracking analysis
(6 9 105 EVs per cell). Cells cultured in EV-depleted MM
and cells cultured in EV-depleted ODM (Table 2) were used
as controls. In addition, we supplementing the MSC culture
medium with UC precipitate from LPS-activation medium
(UC LPS) and LPS-supplemented OCDM (UC OCDM)
that had not been in with cells, to control for the effect of
particles from the culture media coprecipitated with the
EVs.
The cells were cultured at 37 °C and 5% CO2 in a humidi-
fied atmosphere for 18 days or 19 days, during which the
medium was refreshed every 2–3 days. Each time, EVs were
freshly added. At the end of the culture, the wells were
washed in PBS and the contents were collected for analysis.
For analysis of protein secretion, the MSC-conditioned med-
ium was collected, depleted of cell debris by centrifuging for
20 min at 2500 g and stored at 75 °C until further use.
Gene expression analyses by microarrays and
quantitative PCR
Total RNA was isolated from MSCs using the miRCUR-
YTM RNA Isolation Kit (Exiqon A/S) according to the
manufacturer’s instructions. Concentration and purity of
RNA was measured with the Agilent 2200 TapeStation
(Agilent Technologies, Foster City, CA, USA) or Nano-
Drop-1000 (Thermo Fisher Scientific).
For the microarray analysis, the RNA from 5 AT-MSC
donors (donor 1–5) was pooled into three distinct pools per
condition. The starting amount of total RNA was 100 ng.
cDNA was generated using GeneChip WT Plus Reagent
Kit (Affymetrix, Inc., Santa Clara, CA, USA). Micorarray
analysis was performed using Clariom D Human Arrays
(Affymetrix), which contain 135 750 human gene probes.
Moderated paired t-tests were performed using the limma
package in R based on Bayesian statistics and fitting of data
to a linear model [54]. A false discovery rate of < 0.05 was
used to filter differentially expressed genes between treat-
ments and control (EV-depleted MM). A heat map was
generated using the expression values of differentially
Table 3. Surface marker expression by AT-MSCs and BM-MSCs used in this study. Cells were defined positive for a surface marker if the
fluorescence level was > 99% of the corresponding unstained cell sample. CD, cluster of differentiation.
Median positive expression (min–max)
CD AT-MSCs (n = 9) BM-MSCs (n = 3)
CD14 LPS receptor, MC and macrophage marker 0.2% (0.0–0.5) 0.2% (0.2–0.4)
CD19 B-lymphocyte surface antigen B4 0.1% (0.0–0.2) 0.1% (0.1–0.2)
CD34 Protein tyrosine phosphatase receptor type C, leucocyte common antigen 13.0% (0.0–38.0) 0.2% (0.1–3.1)
CD45 Protein tyrosine phosphatase receptor type C, leucocyte common antigen 0.2% (0.0–0.7) 0.2% (0.2–0.3)
CD54 ICAM-1 60.8% (3.0–92.2) 13.3% (10.0–14.4)
CD73 ecto-50-nucleotidase 100.0% (96.8–100.0) 99.4% (99.1–99.8)
CD90 Thy-1 T-cell surface glycoprotein 99.9% (96.0–100.0) 97.6% (97.6–97.6)
CD105 Endoglin, part of the TGF beta receptor complex 98.1% (92.0–99.8) 97.3% (95.2–97.4)
HLA-DR Human leucocyte antigen – antigen D related 0.4% (0.1–1.2) 1.5% (0.8–1.6)
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expressed genes transformed to Z-scores and subsequent
hierarchical clustering based on Euclidean distances.
The microarray data discussed in this publication have
been deposited in NCBI’s Gene Expression Omnibus [55]
and are accessible through GEO Series accession number
GSE102401.
Functional enrichment was assessed by enrichment analy-
sis of gene ontology terms for genes differentially expressed
in the presence of MC-EVs compared to control (EV-
depleted MM). GOSTATS package (v3.5) for R was used to
compute the hypergeometric test and detect significantly
over-represented biological processes and molecular func-
tions affected by changes in the transcriptome [56]. Each list
of differentially expressed transcripts was tested against the
total list of transcripts in our analysis after filtering out tran-
scripts without Entrez Gene ID or gene ontology annotation.
Gene expression was analysed using qPCR. Total RNA
was converted into cDNA by reverse transcription using a
High-Capacity cDNA Reverse Transcription Kit (Thermo
Fisher Scientific). The expression of specific genes was
quantified using TaqMan assays (Thermo Fisher Scien-
tific) for the following genes: aggrecan (ACAN, assay ID
Hs00153936_m1), alkaline phosphatase, liver/bone/kidney
(ALPL, assay ID Hs01029144_m1), bone morphogenetic
protein 2 (BMP2, assay ID Hs00154192_m1), collagen
type XV alpha 1 chain (COL15A1, assay ID Hs00266332_
m1), C–X–C motif chemokine 5 (CXCL5, assay ID
Hs00171085_m1), fibrinogen like 2 (FGL2, assay ID
Hs00173847_m1), ICAM1 (assay ID Hs00164932_m1), inte-
grin subunit alpha 3 (ITGA3, assay ID Hs01076879_m1),
matrix metallopeptidase 1 (MMP1, assay ID Hs00899658_
m1) and runt-related transcription factor 2 (RUNX2, assay
ID Hs01047973_m1). Genes were selected based on their
established relevance to osteogenesis, or based on their dif-
ferential expression in the presence of EVs compared to
EV-depleted MM in our array data. The PCR reactions
were conducted in triplicates in an Applied Biosystems
7500 Fast Real-Time PCR System (Thermo Fisher Scien-
tific). The results were adjusted for the efficiency of the
chain reactions according to the method described by Yuan
et al. [57] and normalized to the geometrical average of
multiple reference genes: ribosomal protein lateral stalk
subunit P0 (RPLP0, assay ID Hs99999902_m1), TATA-
binding protein (TBP, assay ID Hs00427620_m1) and
YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-mono-
oxygenase activation protein zeta, assay ID Hs03044281_
g1), which have been shown to be stably expressed under
several experimental conditions [58].
Biochemical analyses
Adipose tissue-MSCs (donors 1–6) were lysed in 0.1%
triton-x-100 (Sigma-Aldrich) and frozen at 75 °C. Alka-
line phosphate activity was measured by mixing the cell
lysate with p-nitrophenyl phosphate (Sigma-Aldrich) and
2-amino-2-methyl-1-propanol (Sigma-Aldrich). The amount
of produced p-nitrophenol was measured in a VictorTM X4
multiplate reader (PerkinElmer Inc., Waltham, MA, USA)
at 405 nm.
Total collagen content was quantified using a hydrox-
yproline assay (Sigma-Aldrich). Hydroxyproline content is
a good measure of total collagen content, assuming that
elastin content is negligible [59]. The cell lysate was hydrol-
ysed in 6 N hydrochloric acid (Sigma-Aldrich) at 110 °C
for 3 h followed by quantification of hydroxyproline con-
tent based on the reaction of oxidized hydroxyproline with
4-(dimethylamino)benzaldehyde. Absorbance was measured
at 544 nm in the multiplate reader.
To normalize the alkaline phosphate activity and total
collagen content for cell number, the amount of DNA in
the cell culture lysates was quantified using 0.2 lgmL1
Hoechst 33258 nucleic acid stain (Bio-Rad Laboratories
Inc.) with purified calf thymus DNA as a standard (Bio-
Rad). Fluorescence was measured with the multiplate
reader using excitation at 360 nm and emission at 460 nm.
Cytometric bead arrays for quantification of
protein secretion
The concentration of ILs and chemokines in the AT-MSC-
(donors 7–9) and BM-MSC-conditioned media were
analysed using cytometric bead arrays according to the
manufacturer’s instruction on a BD Accuri C6 flow
cytometer. In addition, we analysed the unconditioned
(EV-supplemented) media to check for proteins present in
the media without the MSCs. We employed a human che-
mokine kit with specific antibodies for IL-8, CCL5,
CXCL9, CCL2, and CXCL10 (BD Biosciences, cat. no.
552990) and a flex set array for IL-6 (BD Biosciences, cat.
no. 558276) on 1 : 100 diluted conditioned media. Undi-
luted media were analysed with a flex set array for soluble
ICAM-1 (BD Biosciences, cat. no. 560269). CBA output
data were analysed using FCAP ARRAY software version 3.0
(BD Biosciences).
Statistical analyses
Statistical analyses were performed with R Statistical Soft-
ware. The effects of medium composition and EV source
on alkaline phosphatase activity, total collagen content
(Fig. 11) and gene expression levels (Fig. 8) in AT-MSC
cultures were analysed using Kruskal–Wallis one-way anal-
ysis of variance by ranks. Mann–Whitney U post hoc tests
were conducted to analyse specific conditions against the
control (EV-depleted MM) for significant differences.
Paired t-tests were performed to test for statistically signifi-
cant differences in gene expression (Fig. 12) and secreted
protein levels (Fig. 13) between MSCs exposed to MC-EVs
and UC LPS, between OC-EVs and UC OCDM, as well as
ODM, UC LSPS and UC OCDM against MM. The results
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were considered significant when the false discovery rate-
controlled P-value was below 0.05.
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